Gonadorelin
GnRH / LHRH / Factrel / Lutrepulse
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH), identical in structure to the endogenous hypothalamic decapeptide that controls reproductive hormone secretion. When administered in pulsatile fashion, it stimulates the anterior pituitary to release both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is used clinically for diagnostic testing of pituitary function and therapeutically to maintain fertility during testosterone replacement therapy.
作用机制
Synthetic analog of endogenous gonadotropin-releasing hormone (GnRH). Pulsatile administration stimulates FSH and LH release from the anterior pituitary. Continuous administration paradoxically downregulates the HPG axis through receptor desensitization.
研究协议
仅供研究使用,非医疗建议。
Pulsatile protocols use 25-100mcg subcutaneously every 90-120 minutes via pump to mimic natural GnRH pulses. Diagnostic test protocols use a single 100mcg IV dose. Continuous dosing protocols (suppressive) not commonly used with the native peptide.
研究笔记
Clinical Research Status
Gonadorelin has FDA approval as a diagnostic agent (Factrel) for evaluating pituitary gonadotroph function and in pulsatile form (Lutrepulse) for hypothalamic amenorrhea, though the latter formulation has been discontinued. It is increasingly prescribed off-label by TRT clinics as an alternative to HCG for maintaining LH/FSH secretion and testicular function. Current research focuses on its role in preserving spermatogenesis during exogenous testosterone administration.
Key Published Findings
Pulsatile GnRH administration has been demonstrated to restore ovulation in women with hypothalamic amenorrhea with pregnancy rates of 20-30% per cycle. In male patients on TRT, subcutaneous gonadorelin at doses of 100-400 mcg administered two to three times daily can maintain measurable LH and FSH levels. The pulsatile pattern is critical as continuous administration paradoxically suppresses gonadotropin release through receptor downregulation.
Safety Profile
Gonadorelin has an excellent safety profile with minimal systemic side effects when used at appropriate doses. Injection site reactions are the most commonly reported adverse event. Headache, flushing, and abdominal discomfort occur rarely. The main clinical concern is ensuring pulsatile rather than continuous dosing patterns to avoid the paradoxical suppressive effect seen with GnRH agonists.
Comparison to Related Compounds
Unlike HCG which directly stimulates Leydig cells, gonadorelin works upstream by stimulating the pituitary to release endogenous LH and FSH, maintaining more physiological hormonal signaling. Compared to GnRH agonists like leuprolide or triptorelin, gonadorelin at pulsatile doses stimulates rather than suppresses the reproductive axis. It offers a more physiological approach to fertility preservation during TRT but requires more frequent dosing than HCG.
Community Observations
Gonadorelin gained significant popularity after 2020 when compounded HCG became harder to obtain, with many TRT clinics switching patients to gonadorelin protocols. Practitioners note that effective use requires proper dosing frequency (typically twice daily subcutaneous injections) to mimic natural GnRH pulsatility. Some clinicians report that gonadorelin is less reliably effective than HCG for testicular size maintenance, though individual responses vary.
半衰期
~2-4 minutes
复溶
Bacteriostatic water (BAC)
存储
冻干
Refrigerate 2-8C up to 12 months.
复溶后
Refrigerate 2-8C. Use within 14 days.
美国法律状态
又称作
常见问题
什么是 Gonadorelin?
Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH), identical in structure to the endogenous hypothalamic decapeptide that controls reproductive hormone secretion. When administered in pulsatile fashion, it stimulates the anterior pituitary to release both luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It is used clinically for diagnostic testing of pituitary function and therapeutically to maintain fertility during testosterone replacement therapy.
Gonadorelin 如何起作用?
Synthetic analog of endogenous gonadotropin-releasing hormone (GnRH). Pulsatile administration stimulates FSH and LH release from the anterior pituitary. Continuous administration paradoxically downregulates the HPG axis through receptor desensitization.
Gonadorelin 在美国的监管状态是什么?
FDA-approved for diagnostic use (Rx only)
Gonadorelin 的半衰期是多少?
~2-4 minutes
Gonadorelin 还有哪些名称?
GnRH, LHRH, Factrel, Lutrepulse
Peptide Contacts仅提供基于研究的摘要,仅供信息参考。我们不托管、分发或支持供应商文档。所有证书分析、GMP证书和供应商通信必须由买家直接请求并验证。本平台上任何内容均不构成法律、医疗或专业建议。用户在购买任何研究化学品之前应自行核实供应商资质,并确保遵守所有适用的当地、州及联邦法律法规,承担全部法律责任。
阅读完整免责声明